Aim Immunotech Inc (AIMID)

$9.50 +2.80 (41.79%)
Market Cap 7.26M
Revenue (ttm) 170,000.00
Net Income (ttm) -17.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,188.24%
Debt to Equity Ratio 0.00
Volume 5,200
Avg Vol 4,391
Day's Range N/A - N/A
Shares Out 764,000.00
Stochastic %K 93%
Beta 0.94
Analysts Strong Sell
Price Target $125.00
Latest News on AIMID
No data available.